GlassScriptPhysician profile
Anuj Shah
NPI 1023639036
$6,609.07
in general payments reported to CMS, 2019-2025
9 companies · $6,609 in 2025
The $6,609 reported for 2025 was more than what 92% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $6,609.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,438 · Food and Beverage: $2,171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,438.00 |
| Food and Beverage | $2,171.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,915.67 | 2025 | Proclaim, Eterna |
| Spinal Simplicity, LLC | $1,529.12 | 2025 | Ha Minuteman G3-R |
| Boston Scientific Corporation | $1,238.08 | 2025 | General - Therapies, Intracept |
| Saluda Medical Americas, INC. | $532.22 | 2025 | Evoke |
| Bioventus LLC | $109.83 | 2025 | Stimrouter Implantable Kit |
| Foundation Fusion Solutions, LLC | $99.69 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $89.56 | 2025 | |
| Medtronic, INC. | $74.72 | 2025 | |
| Stryker Corporation | $20.18 | 2025 | Optablate, Spinejack |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anuj Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.